Issue navigation
Volume 30, Issue 3, March 2015
Cutting-Edge Renal Science
IN FOCUS
Warfarin therapy for atrial fibrillation in haemodialysis patients: mind the (evidence) gap
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 337–339, https://doi.org/10.1093/ndt/gfu412
Progenitor cell-derived extracellular vesicles: an emerging diagnostic and therapeutic tool for renal disease
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 339–341, https://doi.org/10.1093/ndt/gfv027
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 342–344, https://doi.org/10.1093/ndt/gfu191
POLAR VIEWS IN NEPHROLOGY
Pro: Cardiovascular calcifications are clinically relevant
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 345–351, https://doi.org/10.1093/ndt/gfv020
Opponent's comments
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 351–352, https://doi.org/10.1093/ndt/gfv020a
Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 352–357, https://doi.org/10.1093/ndt/gfv021
Opponent's comments
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Page 357, https://doi.org/10.1093/ndt/gfv021a
Moderator's view: Treatment of vascular calcification is a physical impossibility, so far
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 358–359, https://doi.org/10.1093/ndt/gfv019
REVIEWS - CLINICAL SCIENCE AND OUTCOME RESEARCH IN NEPHROLOGY
The intestine–renal connection in IgA nephropathy
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 360–366, https://doi.org/10.1093/ndt/gfu343
Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 366–375, https://doi.org/10.1093/ndt/gfu067
Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 375–384, https://doi.org/10.1093/ndt/gfu035
REVIEWS - BASIC SCIENCE AND TRANSLATIONAL NEPHROLOGY
Potential role of Akt signaling in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 385–394, https://doi.org/10.1093/ndt/gfu196
‘That Obscure Object of Desire’: in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 394–400, https://doi.org/10.1093/ndt/gfu213
Original Articles
BASIC SCIENCE
Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 401–409, https://doi.org/10.1093/ndt/gfu346
Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 410–422, https://doi.org/10.1093/ndt/gfu364
…nano-sized fragments surrounded by a lipid membrane [extracellular vesicles (EVS)] are routinely released by virtually all cell types…and their composition may change in disease states…EVs may therefore represent useful biomarkers…
The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 423–433, https://doi.org/10.1093/ndt/gfu311
Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 434–440, https://doi.org/10.1093/ndt/gfu318
CLINICAL SCIENCE
Chronic Kidney Disease
Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 441–451, https://doi.org/10.1093/ndt/gfu294
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 451–460, https://doi.org/10.1093/ndt/gfu297
Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 460–466, https://doi.org/10.1093/ndt/gfu312
Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 467–474, https://doi.org/10.1093/ndt/gfu306
Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 475–480, https://doi.org/10.1093/ndt/gfu329
Circulating and renal vein levels of microRNAs in patients with renal artery stenosis
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 480–490, https://doi.org/10.1093/ndt/gfu341
Intra- and Extracorporeal Treatments of Kidney Failure
Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 491–498, https://doi.org/10.1093/ndt/gfu334
…the issue of whether to anticoagulate or not is far from resolved and this prospective study by Genovesi et al. teaches us that although haemodialysis patients with atrial fibrillation treated with warfarin are at high risk of bleeding…the net clinical benefit of warfarin use in HD patients is not yet established, and the debate will only be resolved when a randomized controlled trial clarifies this conundrum.
Prescription of potentially inappropriate medications to elderly hemodialysis patients: prevalence and predictors
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 498–505, https://doi.org/10.1093/ndt/gfu070
Ranking of factors determining potassium mass balance in bicarbonate haemodialysis
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 505–513, https://doi.org/10.1093/ndt/gfu376
Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Pages 513–520, https://doi.org/10.1093/ndt/gfu327
Announcements
Announcements
Nephrology Dialysis Transplantation, Volume 30, Issue 3, March 2015, Page 521, https://doi.org/10.1093/ndt/gfv039
